Failure of lithium treatment in established tardive dyskinesia
- PMID: 7003639
- DOI: 10.1017/s0033291700047498
Failure of lithium treatment in established tardive dyskinesia
Abstract
Eleven patients with tardive dyskinesia were treated with lithium carbonate in a placebo-controlled double-blind crossover study. No significant effect of lithium on either tardive dyskinesia or blood prolactin concentrations was demonstrated, but 5 patients developed pseudo-Parkinsonian features.